Efficacy of Mentha spicata essential oil in suppression of Aspergillus flavus and aflatoxin contamination in chickpea with particular emphasis to mode of antifungal action

Protoplasma
Akash KediaNawal Kishore Dubey

Abstract

The present study reports in vivo antifungal and antiaflatoxigenic efficacy of Mentha spicata essential oil (EO) against toxigenic Aspergillus flavus strain LHP(C)-D6 in chickpea food system up to 12 months of storage. In addition, the mode of antifungal action of EO was also determined to understand the mechanism of fungal growth inhibition. The in vivo study with different concentrations of M. spicata EO showed dose-dependent decrease in fungal colony count as well as aflatoxin B1 concentration. The EO caused >50% protection in inoculated sets and >70% protection in uninoculated sets of chickpea food system against A. flavus at 1.0 μL mL(-1) air concentration. However, at the same concentration, EO caused 100% inhibition to aflatoxin B1 production in both sets when analyzed through high-performance liquid chromatography (HPLC). The antifungal target of EO in fumigated cells of A. flavus was found to be the plasma membrane when analyzed through electron microscopic observations and ions leakage test. The EO fumigated chickpea seeds showed 100% seed germination and seedling growth after 12 months of storage. Based on these observations, M. spicata EO can be recommended as plant-based preservative for safe protection of food com...Continue Reading

References

Sep 12, 1986·Science·M C GustinC Kung
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J A RamirezH Lecar
Jun 18, 2003·Phytochemistry·Anjali PrasharChristine S Evans
Jul 15, 2003·Clinical Microbiology Reviews·J W Bennett, M Klich
Oct 3, 2003·Journal of Cataract and Refractive Surgery·Jan S Peterson
Jul 13, 2004·International Journal of Food Microbiology·Sara Burt
Nov 9, 2004·The American Journal of Clinical Nutrition·Jonathan H WilliamsDeepak Aggarwal
May 29, 2007·Microbiology·M T HedayatiD W Denning
Nov 13, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·F BakkaliM Idaomar
Jan 13, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marina D SokovićLeo J L D van Griensven
Feb 14, 2009·Bioorganic & Medicinal Chemistry·Franck E DayanStephen O Duke
Nov 1, 2007·Molecular Plant Pathology·Maren A Klich

❮ Previous
Next ❯

Citations

Mar 24, 2016·Protoplasma·Bhumi Nath Tripathi
Jan 29, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Anand Kumar ChaudhariNawal Kishore Dubey
Jul 9, 2020·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Anand Kumar ChaudhariNawal Kishore Dubey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

© 2021 Meta ULC. All rights reserved